BC

Belinda Cairns

Director Of Histopathology at Oxford BioTherapeutics

Belinda Cairns has extensive experience in histopathology, holding various titles such as Director of Histopathology, Principal Scientist, and Senior Scientist in companies such as Oxford BioTherapeutics, AbbVie, and Allergan Inc. Belinda has a Ph.D. in Neuroscience from the University of Oxford. Belinda's expertise includes leading IHC coordination, developing new methods for tissue evaluation, and managing experimental pathology departments to support research drug discovery and translational medicine.

Links

Previous companies

AbbVie logo

Timeline

  • Director Of Histopathology

    May 1, 2024 - present

  • Associate Director

    May, 2021

View in org chart